Note : Image shown for reference purposes only. Actual product appearance may vary. Please read product description for full and accurate details

GoodSense Children's Ibuprofen 100 Mg Oral Suspension Grape 4 Oz - Potential Constraints through 2024

In stock
SKU
MPSPERR-LP66026
More Information
Brand Perrigo
MPN LP66026
Packaging 48/case
$230.42

Details

Compare to Childrens Motrin active ingredient

Children's Ibuprofen Oral Suspension 100 mg per 5 mL, Grape Flavor, 4 fl oz /each count, (48 units per case)

About the product

  • THE ACTIVE INGREDIENT in GoodSense Children's Ibuprofen Oral Suspension is ibuprofen 100 mg per 5 mL, a pain reliever and fever reducer for children ages 2 to 11 years. Compare to the active ingredient in Childrens Motrin.
  • HELP YOUR child get back on track with GoodSense Children's Ibuprofen Oral Suspension 100 mg per 5 mL, a nonsteroidal anti-inflammatory drug that reduces fever and relieves minor aches and pains of the common cold, flu, sore throat, headache and toothache.
  • MADE FOR CHILDREN: GoodSense Children's Ibuprofen Oral Suspension, 100 mg per 5 mL comes in grape flavor, and is a pain reliever and fever reducer specifically formulated for children ages 2 to 11. Plus the container features a child-resistant safety cap.
  • ONE DOSE provides relief of pain and fever for up to 8 hours. Dosage cup included.
  • GLUTEN FREE: This children's pain reliever and fever reducer is gluten free and contains no alcohol.

Specifications

Compare To
Compare to Children's Motrin active ingredient
Active Ingredients
Ibuprofen 100 mg (NSAID)* *nonsteroidal anti-inflammatory drug
Item Size 4 OZ
Case Pack Quantity 48
Case UPC 50301130660269
Case Dimensions 17.23 X 12.96 X 5.52
Case Weight 20.64
Case Pack Inner Quantity 6
Cases Per Pallet 56
Ti/Hi 8 X 7
Cube 0.72
Item UPC Code 301130660264
Product Dimensions 2.03 X 2.0 X 5.12
Inner Pack UPC NONE
NDC 0113-0660-26
National Brand UPC 45060304
Write Your Own Review
You're reviewing:GoodSense Children's Ibuprofen 100 Mg Oral Suspension Grape 4 Oz - Potential Constraints through 2024
Your Rating
Top